Eam Investors, LLC Charles River Laboratories International, Inc. Transaction History

Eam Investors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$222.0 - $252.62 $1.2 Million - $1.37 Million	-5,417 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$175.56 - $226.45 $365,867 - $471,921	-2,084 Reduced 27.78%	5,417 $1.23 Million
Q2 2020 Aug 13, 2020	SELL	$118.84 - $189.72 $540,127 - $862,277	-4,545 Reduced 37.73%	7,501 $1.31 Million
Q1 2020 May 13, 2020	BUY	$98.9 - $178.34 $1.19 Million - $2.15 Million	12,046 New	12,046 $1.52 Million

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.96B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.